Britain Approves Eli Lilly's Weight Loss Drugs
Britain has approved the use of the drug "Orforglibreon" for weight loss and controlling Type 2 diabetes. This oral medication was developed by the American company "Eli Lilly," making the UK the first European country to authorize this drug. This decision follows a thorough review of its safety and efficacy. The medication belongs to the class of drugs known as "GLP-1" used to treat obesity and diabetes. The drug is available in the United States under the name "Vondaio," and pharmaceutical companies are working to develop non-injectable alternatives for obesity, amid increasing competition in this market.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)